These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 34479728)

  • 21. Mepolizumab (Nucala) for severe eosinophilic asthma.
    Med Lett Drugs Ther; 2016 Jan; 58(1486):11-2. PubMed ID: 26761344
    [No Abstract]   [Full Text] [Related]  

  • 22. Prospects for new and emerging therapeutics in severe asthma: the role of biologics.
    Kepil Özdemir S; Bavbek S
    Expert Rev Respir Med; 2017 Jun; 11(6):505-512. PubMed ID: 28464704
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New Treatments for Asthma.
    Huang J; Pansare M
    Pediatr Clin North Am; 2019 Oct; 66(5):925-939. PubMed ID: 31466682
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of Biologics in Asthma.
    McGregor MC; Krings JG; Nair P; Castro M
    Am J Respir Crit Care Med; 2019 Feb; 199(4):433-445. PubMed ID: 30525902
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Home Administration of Biologics for Severe Asthma-A Good Option for Some but Not All.
    Upham JW
    J Allergy Clin Immunol Pract; 2022 Sep; 10(9):2324-2325. PubMed ID: 36087943
    [No Abstract]   [Full Text] [Related]  

  • 26. Pediatric asthma.
    Mueller HP; Fischer W; Cave DG
    Manag Care Interface; 1999 Oct; 12(10):44-6. PubMed ID: 10623005
    [No Abstract]   [Full Text] [Related]  

  • 27. The Effectiveness and Value of Biologic Therapies for the Treatment of Uncontrolled Asthma.
    Tice JA; Campbell JD; Synnott PG; Walsh JME; Kumar VM; Whittington M; Adair E; Rind D; Pearson SD
    J Manag Care Spec Pharm; 2019 May; 25(5):510-514. PubMed ID: 31039065
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [THE EFFECTS OF LAMA ON ASTHMA AND THE THERAPY OF BIOLOGICAL AGENTS IN SEVERE ASTHMA].
    Tagaya E
    Arerugi; 2019; 68(8):904-910. PubMed ID: 31534099
    [No Abstract]   [Full Text] [Related]  

  • 29. Biologics for Severe Asthma: Treatment-Specific Effects Are Important in Choosing a Specific Agent.
    Krings JG; McGregor MC; Bacharier LB; Castro M
    J Allergy Clin Immunol Pract; 2019; 7(5):1379-1392. PubMed ID: 31076056
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [THE INTRODUCTION AND CHOICE OF BIOLOGICS IN ADULT ASTHMA].
    Nagasaki T; Matsumoto H
    Arerugi; 2021; 70(5):349-358. PubMed ID: 34275990
    [No Abstract]   [Full Text] [Related]  

  • 31. Current and future targeted therapies for severe asthma: Managing treatment with biologics based on phenotypes and biomarkers.
    Santus P; Saad M; Damiani G; Patella V; Radovanovic D
    Pharmacol Res; 2019 Aug; 146():104296. PubMed ID: 31173886
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Have we reached our final destination with biologics in severe uncontrolled asthma?
    Lipworth B; Chan R
    J Allergy Clin Immunol Pract; 2023 May; 11(5):1575-1576. PubMed ID: 37150550
    [No Abstract]   [Full Text] [Related]  

  • 33. Biologic Targeting: New and Effective Therapeutic Approaches against Severe Asthma.
    Yang X; Feng HR; Chen ZM; Ying SM
    Chin Med J (Engl); 2018 May; 131(9):1009-1012. PubMed ID: 29692369
    [No Abstract]   [Full Text] [Related]  

  • 34. Reply to "Have we reached our final destination with biologics in severe uncontrolled asthma?".
    Portacci A; Carpagnano GE
    J Allergy Clin Immunol Pract; 2023 May; 11(5):1577. PubMed ID: 37150551
    [No Abstract]   [Full Text] [Related]  

  • 35. Biologics in the Treatment of Asthma.
    Casan Clarà P; Martínez González C
    Arch Bronconeumol (Engl Ed); 2020 Mar; 56(3):137-138. PubMed ID: 31126707
    [No Abstract]   [Full Text] [Related]  

  • 36. Anti-IL5/IL5R switching between biologics in patients with severe eosinophilic asthma.
    Yılmaz İ; Çetin GP; Arslan B
    J Allergy Clin Immunol Pract; 2022 Jul; 10(7):1935-1936. PubMed ID: 35809995
    [No Abstract]   [Full Text] [Related]  

  • 37. Biologic and New Therapies in Asthma.
    Tabatabaian F; Ledford DK; Casale TB
    Immunol Allergy Clin North Am; 2017 May; 37(2):329-343. PubMed ID: 28366480
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Severe asthma, biologicals, and auto-injection: Yes, no, may be!
    Lombardi C; Passalacqua G; Bagnasco D
    Allergy; 2020 Feb; 75(2):444-445. PubMed ID: 31318070
    [No Abstract]   [Full Text] [Related]  

  • 39. Evaluating response to biologics in severe asthma: Precision or guesstimation?
    Taillé C; Devillier P; Dusser D; Humbert M; Maurer C; Roche N
    Respir Med Res; 2021 Nov; 80():100813. PubMed ID: 34171552
    [No Abstract]   [Full Text] [Related]  

  • 40. Asthma: a disease of variability.
    Congleton J
    Drug Ther Bull; 2021 Apr; 59(4):50. PubMed ID: 33766921
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.